ประเทศ: ออสเตรเลีย
ภาษา: อังกฤษ
แหล่งที่มา: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PHENYLBUTAZONE
CEVA ANIMAL HEALTH PTY LTD
phenylbutazone(1g/Sc)
ORAL SOLUTION/SUSPENSION
PHENYLBUTAZONE ANALGESIC Active 1.0 g/sa
(100x1.5g); 1.5g
VM - Veterinary Medicine
CEVA ANIMAL HEALTH
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
MUSCULOSKELETAL SYSTEM
MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE
Poison schedule: 4; Withholding period: WHP: Meat: NOT TO BE USED in horses in tended for human consumption.; Host/pest details: HORSE: [MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [MUSCULOSKELETAL CONDITIONS]; For the treatment of musculo-skeletal disorders in horses.NOT TO BE USED in horses intended for human consumption.
Stopped
2020-07-01
Page 1 of 1 --~-------~------ _ .. _----------------". _. --- Draft Label - DELTAZONE EQUINE ORAL PHENYl.BUTAZONE FOR HORSES 11th November, 2002 1.5 G SACHET Version 2 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY DELTAZONE EQUINE ORAL PHENYLBUTAZONE FOR HORSES ACTIVE CONSTITUENT: Each 1.59 sachet contains: 19 PHENYLBUTAZONE , FOR THE TREATMENT OF MUSCULO-SKELETAL DISORDERS IN HORSES 1.5,g NET DELVET Ply Ltd B4, 26 POWERS RD, SEVEN HILLS NSW AUSTRALIA 2147 DIRECTIONS FOR USE: DOSAGE AND ADMINISTRATION HORSES: 450kg bodyweight: 2 sachets twice on day 1 1 sachet twice daily for 4 days 1 sachet daily or on alternate days. PONIES: 225 kg bodyweight: 1 sachet daily for 4 days followed by 1 sachet on alternate days. MEAT WITHHOLDING PERIOD: NOT TO BE USED IN HORSES INTENDED FOR HUMAN CONSUMPTION. DISPOSAL: Dispose of empty container by wrapping with paper and placing in the garbage. STORAGE: Store below 30 0e (Room Temperature) [8]: Exp: NRA Approval No: 56bl~ \\\D'L Draft Label - DElTAZONE EQUINE ORAL PHENYLBUTAZONE FOR HORSES 11th November, 2002 Carton Version 2 Page 1 of 1 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY - .. DELTAZONE EQUINE ORAL PHENYLBUTAZONE FOR HORSES ACTIVE CONSTITUENT: Each 1.5g sachet contains: 19 PHENYLBUTAZONE FOR THE TREATMENT OF MUSCULO-SKELETAL DISORDERS IN HORSES 100 Sachets DELVET PTY LTD B4, 26 Powers Rd, Seven Hills NSW Australia 2147 DIRECTIONS FOR USE: DOSAGE AND ADMINISTRATION HORSES: 450kg bodyweight: 2 sachets twice on day 1 1 sachet twice daily for 4 days 1 sachet daily or on alternate days PONIES: 225 kg bodyweight: 1 sachet daily for 4 days followed by 1 sachet on alternate days. MEAT WITHHOLDING PERIOD: NOT TO BE USED IN HORSES INTENDED FOR HUMAN CONSUMPTION. DISPOSAL: Dispose of empty container by wrapping with paper and placing in the garbage. STORAGE: Store below _30_ D _e_ (Room Temperature) [B] : NRA Approval No: Exp: '566 ~ \\ \0"- อ่านเอกสารฉบับเต็ม
PRODUCT NAME: DELTAZONE EQUINE PAGE: 1 OF 4 8 0 0 2 , R E B O T C O : D E U S S I N O I S I V E R S I H T MATERIAL SAFETY DATA SHEET 4 4 8 8 4 2 6 9 2 1 6 + : E N O H P CEVA DELVET PTY LTD : Y B D E U S S I POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY 4 4 8 8 4 2 6 9 2 1 6 + : E N O H P D T L Y T P T E V L E D 4 4 5 1 4 2 6 9 2 1 6 + : X A F D R S R E W O P 6 2 7 4 1 2 W S N , LL I H N E V E S SUBSTANCE: Active ingredient is phenylbutazone, a non-steroidal anti-inflammatory. TRADE NAME: DELTAZONE EQUINE APVMA CODE: 56623 PRODUCT USE: For the treatment of musculo-skeletal disorders in horses. CREATION DATE: OCTOBER, 2008 THIS REVISION ISSUED: OCTOBER, 2008 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S22, S25. Do not breathe dust. Avoid contact with eyes. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR: Granulated solid contained in 1.5g sachets. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. POTENTIAL HEALTH EFFECTS INHALATION: SHORT TERM EXPOSURE: Av อ่านเอกสารฉบับเต็ม